PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE

• VAN DIJK M.,
• RAB M.,
• VAN OIRSCHOT B.,
• BOS J.,
• DERICHS C.,
• RIJNEVELD A.,
• CNOSSEN M.,
• NUR E.,
• BIEMOND B.,
• BARTELS M.,
• JANS J.,
• VAN SOLINGE W.,
• SCHUTGENS R.,
• VAN WIJK R.,
• VAN BEERS E.

Affiliations

VAN DIJK M.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS

RAB M.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS

VAN OIRSCHOT B.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS

BOS J.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS

DERICHS C.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS

RIJNEVELD A.

2 Erasmus MC, Rotterdam, NETHERLANDS

CNOSSEN M.

2 Erasmus MC, Rotterdam, NETHERLANDS

NUR E.

3 Amsterdam University Medical Center, Amsterdam, NETHERLANDS

BIEMOND B.

3 Amsterdam University Medical Center, Amsterdam, NETHERLANDS

BARTELS M.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS

JANS J.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS

VAN SOLINGE W.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS

SCHUTGENS R.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS

VAN WIJK R.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS

VAN BEERS E.

1 University Medical Center Utrecht, Utrecht, NETHERLANDS